Local pharma companies queue up for JB Chemicals & Pharmaceuticals indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Mankind Pharma, Dr Reddys Laboratories and Torrent Pharma are among those that have evinced interest in acquiring JB Chemicals & Pharmaceuticals from KKR, said multiple people aware of the development.
JB Pharma, led by CEO Nikhil Chopra, forecasts 12-14% revenue growth and aims to increase Ebitda margins by 27-28% in FY25. The growth is driven by a focus on chronic portfolio, CDMO business expansion, and upcoming acquisition of an ophthalmology drugs portfolio from Novartis. The company s financial performance in FY24 was strong with revenue reaching Rs 3,484 crore.
JB Pharma Q4 net profit up 43% to Rs 126 crore moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.